Paying users zone. Data is hidden behind: .
Get 1-month access to Johnson & Johnson for $19.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Analysis of Revenues
Revenues as Reported
Johnson & Johnson, Income Statement, Revenues
US$ in millions
| 12 months ended: | Dec 31, 2020 | Dec 29, 2019 | Dec 30, 2018 | Dec 31, 2017 | Dec 31, 2016 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Consumer Health | |||||||||||
| Pharmaceutical | |||||||||||
| Medical Devices | |||||||||||
| Sales to customers |
Based on: 10-K (filing date: 2021-02-22), 10-K (filing date: 2020-02-18), 10-K (filing date: 2019-02-20), 10-K (filing date: 2018-02-21), 10-K (filing date: 2017-02-27).
| Item | Description | The company |
|---|---|---|
| Sales to customers | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). | Johnson & Johnson’s sales to customers increased from 2018 to 2019 and from 2019 to 2020. |